Inhaled nitric oxide treatment for preterm infants with hypoxic respiratory failure

Smyth, Rosalind L.
August 2000
Thorax;Aug2000 Supplement 1, Vol. 55, pS51
Academic Journal
No abstract available.


Related Articles

  • Inhaled Nitric Oxide for Preterm Infants – Who Benefits? Martin, Richard J.; Walsh, Michele C. // New England Journal of Medicine;7/7/2005, Vol. 353 Issue 1, p82 

    The article explains the discrepant results of two studies that assessed the utility of inhaled nitric oxide in preterm neonates with respiratory failure. A recent study reports improved cognitive neurodevelopmental outcome in two-year-olds treated with inhaled nitric oxide as neonates. However,...

  • Early inhaled nitric oxide in moderately hypoxemic preterm and term newborns with RDS: the RDS subgroup analysis of the Franco-Belgian iNO Randomized Trial. Truffert, P.; Llado-Paris, J.; Mercier, J.-C.; Dehan, M.; Bréart, G.; Bréart, G; Franco-Belgian iNO Study Group // European Journal of Pediatrics;2003, Vol. 162 Issue 9, p646 

    Investigates the effect of inhaled nitric oxide treatment in moderately hypoxemic newborns. Treatment of respiratory distress syndrome; Pulmonary vasodilation; Reduction of deterioration towards refractory hypoxemic respiratory failure in premature and near-term infants.

  • Inhaled NO for Preterm Infants – Getting to Yes? Stark, Ann R. // New England Journal of Medicine;7/27/2006, Vol. 355 Issue 4, p404 

    The author reflects on the advantages of inhaled nitric oxide (NO) among preterm infants. Lung inflammation linked with mechanical injury may contribute to bronchopulmonary dysplasia among preterm infants. Reports showed that inhaled NO improved oxygenation in preterm infants with severe...

  • Nitric oxide to prevent bronchopulmonary dysplasia.  // Archives of Disease in Childhood;Dec2006, Vol. 91 Issue 12, p1022 

    The article focuses on a study that examines nitric oxide (NO) which is said to prevent bronchopulmonary dysplasia (BPD). There has beenanimal evidence that inhaled NO reduces lung inflammation, improves surfactant function, and promotes lung growth. With this, it might prevent BPD. Multicenter...

  • Inhaled Nitric Oxide in preterm infants: a systematic review and individual patient data meta-analysis. Askie, Lisa M.; Ballard, Roberta A.; Cutter, Gary; Dani, Carlo; Elbourne, Diana; Field, David; Hascoet, Jean-Michel; Hibbs, Anna Maria; Kinsella, John P.; Mercier, Jean-Christophe; Rich, Wade; Schreiber, Michael D.; Srisuparp, Pimol; Subhedar, Nim V.; Van Meurs, Krisa P.; Voysey, Merryn; Barrington, Keith; Ehrenkranz, Richard A.; Finer, Neil // BMC Pediatrics;2010, Vol. 10, p15 

    Background: Preterm infants requiring assisted ventilation are at significant risk of both pulmonary and cerebral injury. Inhaled Nitric Oxide, an effective therapy for pulmonary hypertension and hypoxic respiratory failure in the full term infant, has also been studied in preterm infants. The...

  • AAP Statement on the Use of Inhaled Nitric Oxide. Preboth, Monica // American Family Physician;3/15/2001, Vol. 63 Issue 6, p1238 

    Reports on a statement issued by the Committee on Fetus and Newborn of the American Academy of Pediatrics on the use of inhaled nitric oxide in newborns. Conditions under which inhaled nitric oxide should be administered to the neonate with hypoxic respiratory failure; Description of inhaled...

  • Early use of surfactant and nitric oxide. Null, D M // Journal of Perinatology;Dec2013, Vol. 33 Issue 12, p909 

    The author reflects on the study "Impact of early surfactant and inhaled nitric oxide therapies on outcomes in term/late preterm neonates with moderate hypoxic respiratory failure" by G. G. Konduri and colleagues. He expresses the potential of nitric oxide and surfactant to improve patient...

  • Pushing the boundaries for the use of ECMO in acute hypoxic respiratory failure. Bohn, Desmond // Intensive Care Medicine;Jul2005, Vol. 31 Issue 7, p896 

    Evaluates the efficacy of extracorporeal membrane oxygenation (ECMO) for the treatment of acute hypoxic respiratory failure. Assessment of the changes in ventilation strategy; Effectiveness of the use of high-frequency oscillatory ventilation and inhaled nitric oxide; Advantages and benefits of...

  • Nitric Oxide for Preemies – Not So Fast. Martin, Richard J. // New England Journal of Medicine;11/27/2003, Vol. 349 Issue 22, p2157 

    This article comments on a study which provided evidence that inhaled nitric oxide therapy may be beneficial for preterm infants with respiratory distress syndrome. However, the benefits were only observed among infants whose respiratory distress syndrome was mild or moderate. For infants with...

  • Combination therapy for life-threatening pulmonary hypertension in a premature infant: first report on bosentan use. Radicioni, Maurizio; Bruni, Alessia; Camerini, Piergiorgio // European Journal of Pediatrics;Aug2011, Vol. 170 Issue 8, p1075 

    Premature infants with preterm premature rupture of membranes (PPROM) are at high risk of severe respiratory failure because of lung hypodysplasia associated with persistent pulmonary hypertension of the newborn (PPHN). We describe the clinical course of a 28-week gestation infant with PPROM...


Read the Article


Sign out of this library

Other Topics